Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 63,959 | reported | 19 Mar 2026 | tx 47+540,644−134,978 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4,125 | 68.71 USD | |
| 19 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4,231 | 67.00 USD | |
| 17 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4,084 | 69.42 USD | |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 24,236 | — | |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7,248 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4,790 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 5,022 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7,176 | 0.00 USD | deriv |
| 05 Mar 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 17,161 | 0.00 USD | deriv |
| 05 Mar 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 27,310 | 0.00 USD | deriv |
| 19 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 3,261 | 47.40 USD | |
| 20 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 3,084 | 50.11 USD | |
| 18 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 3,341 | 46.29 USD | |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 19,213 | — | |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7,175 | 0.00 USD | deriv |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7,248 | 0.00 USD | deriv |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4,790 | 0.00 USD | deriv |
| 05 Mar 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 30,628 | 0.00 USD | deriv |
| 05 Mar 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 20,089 | 0.00 USD | deriv |
| 18 Mar 2024 | SALE | Tarsus Pharmaceuticals, Inc. | 4,436 | 30.60 USD | |
| 15 Mar 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 12,038 | — | |
| 15 Mar 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7,248 | 0.00 USD | deriv |
| 15 Mar 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4,790 | 0.00 USD | deriv |
| 07 Mar 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 42,500 | 0.00 USD | deriv |
| 07 Mar 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 28,702 | 0.00 USD | deriv |